ArticlemedRxiv : the preprint server for health sciences2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study.
Hsin Yi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.